Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation - Wikidata - awgldk - TriplyDB

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

http://www.wikidata.org/entity/Q24537575

about

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission B cells in chronic graft-versus-host disease The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells The sentinel within: exploiting the immune system for cancer biomarkers.A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy Current issues in chronic graft-versus-host disease.Polymorphisms in the base excision repair pathway and graft-versus-host disease.High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.H-Y antibody development associates with acute rejection in female patients with male kidney transplants Secondary recurrent miscarriage and H-Y immunity.Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.Recipient B cells are not required for graft-versus-host disease induction.Aberrant B-cell homeostasis in chronic GVHD Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Clinical impact of H-Y alloimmunity Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.Clinical applications for biomarkers of acute and chronic graft-versus-host disease.Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease Rituximab for steroid-refractory chronic graft-versus-host disease.Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the A Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT Are there effective new strategies for the treatment of acute and chronic GvHD?DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.

P2860

Q24539030-071A9E0E-58A2-49E3-9218-1F7922B0A8BD Q26861706-ACB10EEA-BC6E-4E33-9F16-5C9E885D2B49 Q28066083-405C7C38-9142-4E60-A324-546723F1582D Q28076264-AEAFB139-5F0C-4A65-87BC-83C58418ABCC Q28297277-D2EE2845-A504-4030-8B4B-BCD89769DC51 Q33221191-2B8F04D2-52A1-4F8F-B090-8626DDB4D617 Q33267303-790CD243-61DD-4681-8706-E8325B8CEE56 Q33280654-5B537EDF-986F-4E6C-9CB5-6C77A0A94113 Q33492227-9D1A9CEA-B8AF-4BF9-A81E-8685E4882019 Q33583414-349B705E-47C0-4FBF-BC00-5B9DA90F951E Q33709766-34696C8C-5CCB-4D80-9F8B-47DD12B1A16F Q33722678-160FE846-3562-41FD-8A64-2D7A85AC6D53 Q33723635-A346B529-7615-4926-8FBF-EF5B52177631 Q33917187-E83A54A1-B70A-4D44-B65F-7BB012418B61 Q34063337-39F59744-C987-4C5D-B438-6A60327108E6 Q34135089-6053CB87-1D42-458B-9ECB-AAE08D554AB8 Q34147590-5951FB1C-A83F-4088-9D7B-7742D9835411 Q34177424-23C26675-0B62-4921-BE9A-6526B3521D02 Q34275669-D64569CD-EB3C-4821-AAC9-B19990260C69 Q34314427-FB39FA77-7EF1-459A-B2E7-33B5E9A3BDF7 Q34754302-E9C28344-D53F-4A63-949F-6EBDB46F88DB Q35104223-5BB1387A-A1A9-40D3-B014-8E7C7F545FDA Q35171251-068B3162-7A1F-4A60-8170-B7AD8BBF42C8 Q35224947-21E1DB10-C7BC-4713-9C6A-B11F586E03EE Q35235186-339AA55A-0F77-44BA-840F-4E7DFEF40E4F Q35607308-D0550FB7-71AA-46C4-90F9-E4453F516C8C Q35687151-4AA9C5CA-C573-4749-BC63-8F997E7684FA Q35737769-BC90C5A5-114D-4A30-B635-0CDC45484DFE Q35767289-55497716-DB0C-42C0-AD66-8980E79C3006 Q35784522-5B2B2F18-BF23-47B9-B4A2-676B775AEA97 Q35811966-831FF43A-3A1F-401F-A5D1-DCE55897077C Q35815893-FBA84E97-8A21-4534-BE05-5DBE429AD2C1 Q35848933-77A1ACDD-7165-4860-96BD-338E4D09BAC8 Q35909695-9E102B1D-EA78-4F6A-8049-832D2F5EEA67 Q36057911-077079C1-999C-4E83-A339-EFAFD23A4768 Q36125603-7731EC8B-DF58-4567-851D-34682BF81242 Q36305321-59175CB5-E70C-4E17-954A-43BB8E0CD6C6 Q36579037-63EA307D-EF36-4037-A5A9-8B5847D67928 Q36591409-9BE55F42-6053-4CFE-B08E-D3B663F5F293 Q36830199-26C60510-9D77-4E79-941A-001192D33199

P2860

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

http://www.wikidata.org/entity/Q24537575

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Minor histocompatibility antig ...... neic stem cell transplantation

@ast

Minor histocompatibility antig ...... neic stem cell transplantation

@en

Minor histocompatibility antig ...... neic stem cell transplantation

@nl

type

label

Minor histocompatibility antig ...... neic stem cell transplantation

@ast

Minor histocompatibility antig ...... neic stem cell transplantation

@en

Minor histocompatibility antig ...... neic stem cell transplantation

@nl

prefLabel

Minor histocompatibility antig ...... neic stem cell transplantation

@ast

Minor histocompatibility antig ...... neic stem cell transplantation

@en

Minor histocompatibility antig ...... neic stem cell transplantation

@nl

P1433

Q24537575-89788A51-BD4E-4CD3-97C9-DA8536B1CC51

P1476

Q24537575-B3324DFC-8780-414D-9D0B-5D4A8A13E745

P2093

Q24537575-2DFA7866-9328-4D34-8585-2E0071398418

Q24537575-88EDCD65-CDC2-4901-AF1E-D69B77801A2A

Q24537575-904490AA-4AAB-4734-AD6F-52F3C7A51508

Q24537575-BC7B697C-0F11-4F27-83E3-1B180D3085DA

Q24537575-CAD6779A-B93A-4B92-92E5-DF9F7163B8FE

Q24537575-D3D15012-CA67-402E-98D1-C596C870BD42

Q24537575-E4C80AEB-27A5-43A0-BB93-CC8A0F95F379

P2860

Q24537575-03B11B23-8818-4C7B-9530-F0034ED730F5

Q24537575-03DA1190-BE14-449C-9DDD-486BF6A0040C

Q24537575-0535F547-A03D-4D36-89CD-4F21AE31B8DD

Q24537575-081E5483-3390-492D-9ABA-399EE0688034

Q24537575-13C92C0F-FBDD-400F-A366-12B49D5CADE2

Q24537575-18F27460-0546-4655-A4F7-4317AEFC70EF

Q24537575-1B16E8FD-5E19-4B51-95E5-5588D9ED0CB7

Q24537575-5EE5A7C8-948E-4CF6-96BB-B951C2C33A29

Q24537575-6E8547E5-2968-415B-9EB5-EC22D46FCC3C

Q24537575-8E313169-2B75-451C-9F52-9B41E02D1011

P304

Q24537575-596203D0-D0DF-43CA-A535-B6E21738F17F

P31

Q24537575-4EC71D15-7B60-4664-AC3B-0E90D529D66C

P3181

Q24537575-AA71F4E4-6687-4BBF-B7F8-F13AEC37559C

P356

Q24537575-74B7DCA9-6C55-4CF8-8637-B189584F881E

P407

Q24537575-B2C21631-E51D-47C0-8936-33331BC8B945

P433

Q24537575-DA1A370C-863C-4107-9780-4334AA68F7B4

P478

Q24537575-85D86DD3-E0D2-4F79-9E89-F513AC0D3C4C

P50

Q24537575-8855B794-43EE-4983-BCE7-3A64F5CE97AF

P577

Q24537575-E1B341BC-6A88-4087-B240-20C0724C4116

P5875

Q24537575-A0592827-668C-4753-9C24-4299B1C66E71

P698

Q24537575-4FBC3A96-D471-4A5F-9386-5C286717BEF0

P932

Q24537575-5F892EEF-38E7-45C8-81AD-1E0868442321

P3181

P356

P1433

Journal of Experimental Medicine

P1476

Minor histocompatibility antig ...... neic stem cell transplantation

@en

P2093

Alex Mattes-Ritz

http://www.w3.org/2001/XMLSchema#string

Blair H Floyd

http://www.w3.org/2001/XMLSchema#string

David B Miklos

http://www.w3.org/2001/XMLSchema#string

Emmanuel Zorn

http://www.w3.org/2001/XMLSchema#string

Joseph H Antin

http://www.w3.org/2001/XMLSchema#string

Luxuan Guo

http://www.w3.org/2001/XMLSchema#string

Robert J Soiffer

http://www.w3.org/2001/XMLSchema#string

P2860

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition.

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

P304

1133-1142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3816011

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20031560

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

199

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8606871

http://www.w3.org/2001/XMLSchema#string

P698

15096539

http://www.w3.org/2001/XMLSchema#string

P932

1361263

http://www.w3.org/2001/XMLSchema#string